Skip to main content

Table 1 Exclusion criteria for participants in the EMA study

From: Design and process of the EMA Cohort Study: the value of antenatal education in childbirth and breastfeeding

Multiple pregnancy

Pathological pregnancy

   · Clinically and/or radiographically documented pelvic abnormality

   · Prior uterine malformation

   · Uterine tumour in current pregnancy

   · Prior uterine surgery

   · Prior genital tract abnormality

   · Positive cytologic testing for malignant cells

   · Prior severe medical or surgical disease (maternal heart disease restricting physical capacity of the woman, neuropathy, coagulopathy, diabetes, etc.)

   · Late cerclage, performed after 16 weeks

   · Active toxoplasmosis during pregnancy

   · German measles during pregnancy

   · Sexually transmitted infection during current pregnancy

   · Gestational diabetes

   · Rh isoimmunisation

   · Foetal malformation

   · Placenta previa

   · Pregnancy-induced HBP

   · Hydramnios of 2 or more litres of amniotic fluid

   · Oligohydramnios lower than 500 mL.

   · Bleeding in the third trimester

   · Suspected or documented IUGR

   · Threatened premature birth

Uncontrolled pregnancy*

Difficult follow-up

   · No telephone, fixed abode, and others

Not speaking Spanish or Basque

  1. Adequate pregnancy control: 6 obstetric visits, some of them in the first trimester of pregnancy. (SEGO, 2002).